Clinical Trial: Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: A Prospective, Multicenter, Open-Label, Randomized Clinical Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis
Brief Summary: The purpose of this study is to compare the efficacy (by assessing the clinical success of treatment) of intravenous antibiotic therapy with ertapenem in patients with acute attacks of sigmoid diverticulitis for 4 vs. 7 days.
Detailed Summary:
Sponsor: Klinikum Hanover-Siloah Hospital
Current Primary Outcome:
- Clinical therapeutic success (full regression)
- Relapse rate
- Operation rate
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Development of laboratory parameters
- Duration of hospitalization
- Duration of parenteral feeding
- Incidence of surgical intervention and repeat surgery
- Incidence and duration of intensive care
Original Secondary Outcome: Same as current
Information By: Klinikum Hanover-Siloah Hospital
Dates:
Date Received: November 29, 2004
Date Started: July 2004
Date Completion: June 2007
Last Updated: February 12, 2006
Last Verified: February 2006